| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 142, Issue 10 3378-3383, Copyright © 1989 by American Association of Immunologists
ARTICLES |
I Screpanti, S Morrone, D Meco, A Santoni, A Gulino, R Paolini, A Crisanti, BJ Mathieson and L Frati
Department of Experimental Medicine, University La Sapienza, Rome, Italy.
We have studied the effects of the steroid hormones, 17 beta-estradiol and dexamethasone, on the relative proportion of thymocyte expression of CD4 (L3T4), CD8 (Ly-2), TCR and IL-2R, used to identify different stages of thymocyte differentiation. After short-term in vivo steroid treatment, a significant decrease in the number and proportion of the CD4+/CD8+, double positive subpopulation was observed in parallel with a proportional increase in the percentage of the CD4+/CD8- single positive, of the CD4-/CD8-, double negative and, to a lesser extent, of the CD8+/CD4- subsets. Either steroid treatment increased the proportion of cells expressing either the epsilon-chain of the CD3 complex and/or the beta-chain of the TCR (beta-TCR) (TCR+/CD3+) and the 55 kDa protein of the IL-2R (IL-2R+), related to the increase of CD4+ SP thymocytes and of DN cells, respectively. Furthermore, the increased proportion of CD3+ cells could also be partially related to the increase of both the CD4+ and DN subsets. A decrease of the effect on either DN/IL-2R+ cells or CD4+ SP cells was selectively observed after long-term treatments with 17 beta-estradiol or DEX, respectively. It is concluded that after short-term administration, different steroid hormones mediate a similar selective depletion of DP, TCR-/CD3-, IL2R- cells presumably in an intermediate stage of differentiation. However, either steroid effects evolve differently in long-term treatment schedules, resulting in different effects on early (DN/IL2R+) and late (SP/IL2R-) steps of thymocyte differentiation.
This article has been cited by other articles:
|
|
 |
|
  K. D. Salazar, M. R. Miller, J. B. Barnett, and R. Schafer Evidence for a Novel Endocrine Disruptor: The Pesticide Propanil Requires the Ovaries and Steroid Synthesis to Enhance Humoral Immunity Toxicol. Sci., September 1, 2006; 93(1): 62 - 74. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Zoller and G. J. Kersh Estrogen Induces Thymic Atrophy by Eliminating Early Thymic Progenitors and Inhibiting Proliferation of beta-Selected Thymocytes. J. Immunol., June 15, 2006; 176(12): 7371 - 7378. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Selvaraj, D. Bunick, C. Finnigan-Bunick, R. W. Johnson, H. Wang, L. Liu, and P. S. Cooke Gene Expression Profiling of 17{beta}-Estradiol and Genistein Effects on Mouse Thymus Toxicol. Sci., September 1, 2005; 87(1): 97 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Gilleran, O. Putz, M. DeJong, S. DeJong, L. Birch, Y. Pu, L. Huang, and G. S. Prins The Role of Prolactin in the Prostatic Inflammatory Response to Neonatal Estrogen Endocrinology, May 1, 2003; 144(5): 2046 - 2054. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Do, S. Ryu, M. Nagarkatti, and P. S. Nagarkatti Role of Death Receptor Pathway in Estradiol-Induced T-Cell Apoptosis in Vivo Toxicol. Sci., November 1, 2002; 70(1): 63 - 72. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Zaldumbide, F. Carlotti, P. Pognonec, and K. E. Boulukos The Role of the Ets2 Transcription Factor in the Proliferation, Maturation, and Survival of Mouse Thymocytes J. Immunol., November 1, 2002; 169(9): 4873 - 4881. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Brewer, B. P. Sleckman, W. Swat, and L. J. Muglia Green Fluorescent Protein-Glucocorticoid Receptor Knockin Mice Reveal Dynamic Receptor Modulation During Thymocyte Development J. Immunol., August 1, 2002; 169(3): 1309 - 1318. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Keil, R. W. Luebke, and S. B. Pruett Quantifying the Relationship Between Multiple Immunological Parameters and Host Resistance: Probing the Limits of Reductionism J. Immunol., October 15, 2001; 167(8): 4543 - 4552. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Savino and M. Dardenne Neuroendocrine Control of Thymus Physiology Endocr. Rev., August 1, 2000; 21(4): 412 - 443. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Staples, T. A. Gasiewicz, N. C. Fiore, D. B. Lubahn, K. S. Korach, and A. E. Silverstone Estrogen Receptor {alpha} Is Necessary in Thymic Development and Estradiol-Induced Thymic Alterations J. Immunol., October 15, 1999; 163(8): 4168 - 4174. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. Tibbetts, F. DeMayo, S. Rich, O. M. Conneely, and B. W. O'Malley Progesterone receptors in the thymus are required for thymic involution during pregnancy and for normal fertility PNAS, October 12, 1999; 96(21): 12021 - 12026. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Yagi, U. Dianzani, H. Kato, T. Okamoto, T. Katsurada, D. Buonfiglio, T. Miyoshi-Akiyama, and T. Uchiyama Identification of a New Type of Invariant V{alpha}14+ T Cells and Responsiveness to a Superantigen, Yersinia pseudotuberculosis- Derived Mitogen J. Immunol., September 15, 1999; 163(6): 3083 - 3091. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Wang, J. Wykrzykowska, T. Johnson, R. Sen, and J. Sen A NF-{kappa}B/c-myc-Dependent Survival Pathway Is Targeted by Corticosteroids in Immature Thymocytes J. Immunol., January 1, 1999; 162(1): 314 - 322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. J. Olsen, S. M. Viselli, J. Fan, and W. J. Kovacs Androgens Accelerate Thymocyte Apoptosis Endocrinology, February 1, 1998; 139(2): 748 - 752. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
